Literature DB >> 28948499

CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.

Guobin Zhang1, Yunsheng Zhang2, Sen Cheng2, Zhen Wu1, Fusheng Liu3, Junting Zhang4.   

Abstract

Hypoxia is a major regulator of glioma development and aggressiveness. However, how CD133 positive U87 glioblastoma cells adapt to hypoxia and communicate with their surrounding microenvironment during tumor development remain important questions. Communication with host cells and stroma via exosomes represents one pathway by which tumors can modify their surroundings to achieve a tumor-permissive environment. MicroRNAs are thought to be essential actors of tumorigenesis as they are able to control the expression of numerous genes. Here, we show that exosomes derived from CD133+ U87 glioblastoma cells grown at hypoxic compared with normoxic conditions are potent proliferation inducers of the tumor vasculature and glioma cells proliferation in vitro. Moreover, we analyze the microRNA content of exosomes produced in vitro by hypoxia and normoxia CD133+ U87 glioblastoma cells using Affymetrix microarrays. It appears that the exosome microRNA profiles are qualitatively quite similar. Nevertheless, their quantitative profiles are different and may be potentially taken as an opportunity to carry out assays of diagnostic interest. We conclude that CD133+ U87 glioblastoma cells derived exosome-mediated miRNA transduction play an important role of mediating a proangiogenic response and glioma cells proliferation, and that the exosomal pathway constitutes a potentially targetable driver of hypoxia-dependent intercellular signaling during tumor development.

Entities:  

Keywords:  Exosome; Glioblastoma; Hypoxia; MicroRNA; Normoxia

Mesh:

Substances:

Year:  2017        PMID: 28948499     DOI: 10.1007/s11060-017-2566-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  47 in total

Review 1.  Hypoxia signalling in cancer and approaches to enforce tumour regression.

Authors:  Jacques Pouysségur; Frédéric Dayan; Nathalie M Mazure
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

3.  Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.

Authors:  Jung Eun Park; Hon Sen Tan; Arnab Datta; Ruenn Chai Lai; Huoming Zhang; Wei Meng; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2010-02-01       Impact factor: 5.911

4.  Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.

Authors:  Paulina Kucharzewska; Helena C Christianson; Johanna E Welch; Katrin J Svensson; Erik Fredlund; Markus Ringnér; Matthias Mörgelin; Erika Bourseau-Guilmain; Johan Bengzon; Mattias Belting
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

5.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

6.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

7.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

Review 8.  The extracellular matrix: a dynamic niche in cancer progression.

Authors:  Pengfei Lu; Valerie M Weaver; Zena Werb
Journal:  J Cell Biol       Date:  2012-02-20       Impact factor: 10.539

9.  Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.

Authors:  Corinna Eichelser; Isabel Stückrath; Volkmar Müller; Karin Milde-Langosch; Harriet Wikman; Klaus Pantel; Heidi Schwarzenbach
Journal:  Oncotarget       Date:  2014-10-30

10.  MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.

Authors:  D Chen; Bian-Li Dang; Jin-zhou Huang; Min Chen; Di Wu; Man-Li Xu; Rong Li; Guang-Rong Yan
Journal:  Oncotarget       Date:  2015-10-20
View more
  16 in total

Review 1.  Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence.

Authors:  Michael W Graner
Journal:  Annu Rev Genomics Hum Genet       Date:  2019-04-12       Impact factor: 8.929

Review 2.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

Review 3.  Hypoxia and extracellular vesicles: A review on methods, vesicular cargo and functions.

Authors:  Nea Bister; Cristiana Pistono; Benjamin Huremagic; Jukka Jolkkonen; Rosalba Giugno; Tarja Malm
Journal:  J Extracell Vesicles       Date:  2020-11-14

Review 4.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

Review 5.  Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma.

Authors:  Hélène Grégoire; Loris Roncali; Audrey Rousseau; Michel Chérel; Yves Delneste; Pascale Jeannin; François Hindré; Emmanuel Garcion
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

Review 6.  Extracellular Vesicles in Glioblastoma Tumor Microenvironment.

Authors:  Anuroop Yekula; Anudeep Yekula; Koushik Muralidharan; Keiko Kang; Bob S Carter; Leonora Balaj
Journal:  Front Immunol       Date:  2020-01-21       Impact factor: 7.561

7.  Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.

Authors:  Susannah Hallal; Saeideh Ebrahim Khani; Heng Wei; Maggie Yuk Ting Lee; Hao-Wen Sim; Joanne Sy; Brindha Shivalingam; Michael E Buckland; Kimberley L Alexander-Kaufman
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

Review 8.  Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.

Authors:  Yunping Chen; Yan Jin; Nan Wu
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

Review 9.  Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment.

Authors:  Qi Chen; Yuefeng Li; Yueqin Liu; Wenlin Xu; Xiaolan Zhu
Journal:  Front Cell Dev Biol       Date:  2021-04-12

Review 10.  The Role of Extracellular Vesicles in Cancer: Cargo, Function, and Therapeutic Implications.

Authors:  James Jabalee; Rebecca Towle; Cathie Garnis
Journal:  Cells       Date:  2018-08-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.